Seyitler Kimya Sanayi A.S. (SEYKM) Fair Value & Analysis
Healthcare · TR · Market cap 954M TRY
Fair value as of: Aug 1, 2026
From 9 valuation models · updated today
Share price −0.6% over the past month.
What matters now
- The price sits above even our optimistic bull case (4.63 TRY). The favourable scenario is already priced in.
- Weak quality (40/100) and above fair value at the same time, the margin of safety is missing on both counts.
- A fairly wide model range (2.45 TRY to 4.63 TRY) leaves room in how you read the outcome.
Price vs Fair Value (12 months)
12‑month range 4.30 TRY – 7.63 TRY · fair‑value band 2.45 TRY – 4.63 TRY · the 4.77 TRY price screens above the 3.54 TRY fair value. As of Aug 1, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Seyitler Kimya Sanayi A.S. (SEYKM) currently trades at 4.77 TRY, while our model-based Fair Value estimate is 3.54 TRY, implying the stock looks roughly 25.8% overvalued today. We read business quality at 40/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Seyitler Kimya Sanayi A.S. generated revenue of 251M TRY at a net margin of 3.2%. Revenue grew 11.5% year over year. It earns a return on equity of 1.6%. Net debt stands at 18.7M TRY. Fundamentals as of Aug 1, 2026
Our scenario range runs from 2.45 TRY (bear case) to 4.63 TRY (bull case); at 4.77 TRY, the current price sits above that range. The share trades about 40% below its 52-week high and 28% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -26% fair-value upside, at -26%, SEYKM screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 1, 2026. TTM = trailing twelve months.
Quality Score breakdown
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Seyitler Kimya Sanayi A.S. develops and sells medical adhesive tape products in Turkey, the Middle East, Africa, Europe, and the Americas. The company offers surgical tapes, injection series, wound care, skin closure strip and eye pads, first aid strips, dialysis sets, heat patches, compress and swab, ointments, hemostatic series, and silicone products.
Full company description
Seyitler Kimya Sanayi A.S. develops and sells medical adhesive tape products in Turkey, the Middle East, Africa, Europe, and the Americas. The company offers surgical tapes, injection series, wound care, skin closure strip and eye pads, first aid strips, dialysis sets, heat patches, compress and swab, ointments, hemostatic series, and silicone products. Seyitler Kimya Sanayi A.S. was incorporated in 1991 and is headquartered in Turgutlu, Turkey.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Seyitler Kimya Sanayi A.S. reported revenue of 242M TRY in FY2025 versus 60.2M TRY in FY2021, a compound +41.6%/yr. Reported net income was −39.5M TRY in FY2025.
Is SEYKM fairly valued? → Check now
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Aug 1, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | C$20.93 | C$10.43 | -50% |
| EssilorLuxottica Société anonyme ESLOF | $192.00 | $126.51 | -34% |
| Medline Inc MDLN | $33.61 | $31.78 | -5% |
| HOYA Corporation HOCPY | $158.38 | $101.00 | -36% |
| Becton, Dickinson and Company BDX | $140.71 | $104.17 | -26% |
| Alcon Inc 2U3 | €57.16 | €44.21 | -23% |
| ResMed Inc RMD | $193.57 | $187.89 | -3% |
| West Pharmaceutical Services, Inc WST | $329.71 | $137.28 | -58% |
| Terumo Corporation TRUMF | $14.62 | $12.65 | -13% |
| Straumann Holding SAUHY | $12.68 | $5.49 | -57% |
Compare Seyitler Kimya Sanayi A.S. with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Seyitler Kimya Sanayi A.S. (SEYKM) overvalued or undervalued?
What is the fair value of SEYKM?
What is the quality score of SEYKM?
What is the revenue of Seyitler Kimya Sanayi A.S. (SEYKM)?
What is the net profit margin of SEYKM?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Seyitler Kimya Sanayi A.S. and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.